Citigroup
WST icon

Citigroup’s West Pharmaceutical WST Stock Holding History

Citigroup’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,500
Closed -$1.38M – 7870
2019
Q1 		$1.38M Buy
+12,500
New +$1.3M ﹤0.01% 3048

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup's WST Position: Q1 2026 in Review

Citigroup reduced its West Pharmaceutical (WST) stake by 2.2% in Q1 2026, selling an estimated $802K and leaving 142,434 shares worth $35.7M. The position accounts for 0.02% of the portfolio, ranked #783.

Citigroup first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.1M in Q4 2020. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Citigroup held 142,434 shares of West Pharmaceutical worth $35.7M as of Q1 2026.
  • Citigroup sold 3,222 West Pharmaceutical shares in Q1 2026, an estimated $802K.
  • West Pharmaceutical made up 0.02% of Citigroup's portfolio in Q1 2026, its #783 holding.
  • Citigroup first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's West Pharmaceutical position peaked at $42.1M in Q4 2020.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.